GlassScriptPhysician profile
David Forsh
NPI 1538333893
$572,956.03
in general payments reported to CMS, 2019-2025
14 companies · $213K in 2025
The $213K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $40K · 2021: $46K · 2022: $60K · 2023: $74K · 2024: $81K · 2025: $213K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $187K · Royalty Or License: $118K · Travel and Lodging: $40K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $11K · Education: $24.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $187,325.00 |
| Royalty Or License | $117,848.56 |
| Travel and Lodging | $39,913.94 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,000.00 |
| Food and Beverage | $10,837.50 |
| Education | $24.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $494,350.72 | 2019-2025 | Pangea, Gamma, Axsos |
| Synthes Gmbh | $72,038.41 | 2019-2025 | |
| Medical Device Business Services, INC. | $4,020.27 | 2024-2025 | Lcp, Na |
| Globus Medical, INC. | $1,354.32 | 2024-2025 | Excelsius Gps, Distal Tibia Plating, Autobahn |
| Depuy Synthes Sales INC. | $291.24 | 2019-2025 | Na, Va-Lcp, Motoband |
| Solventum Corporation | $183.11 | 2025 | Prevena |
| Si-Bone, INC. | $142.52 | 2021 | |
| Medtronic, INC. | $128.87 | 2023 | Cd Horizon Spinal System |
| Integra Lifesciences Corporation | $121.88 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Djo, LLC | $110.58 | 2024 | Cmf |
| Zimmer Biomet Holdings, INC. | $96.95 | 2023 | Arcos |
| Organogenesis INC. | $71.41 | 2023 | Puraply |
| Kerecis Limited | $45.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Forsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.